Do genetic markers aid in risk assessment?
Department of Medicine and Therapeutics, University of Aberdeen, UK. s.ralston@abdn.ac.uk
S H
SH
Ralston
D015519:Bone Density; D003094:Collagen / Q000235:genetics; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000235:genetics*; D011110:Polymorphism, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics; D011960:Receptors, Estrogen / Q000235:genetics; D018570:Risk Assessment; D016212:Transforming Growth Factor beta / Q000235:genetics
D005819:Genetic Markers; D015850:Interleukin-6; D018167:Receptors, Calcitriol; D011960:Receptors, Estrogen; D016212:Transforming Growth Factor beta; D003094:Collagen